SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001564590-18-001849
Filing Date
2018-02-12
Accepted
2018-02-12 16:00:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sbph-sc13ga.htm SC 13G/A 71706
  Complete submission text file 0001564590-18-001849.txt   72952
Mailing Address C/O SPRING BANK PHARMACEUTICALS, INC. STE S-7 MILFORD MA 01757
Business Address
Eichler Kurt M (Filed by) CIK: 0001424591 (see all company filings)

Type: SC 13G/A

Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Subject) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89626 | Film No.: 18596277
SIC: 2834 Pharmaceutical Preparations